Edward S Greenberg

Title: **Edward S Greenberg: Innovator in Controlled Release Technologies**

Introduction

Edward S Greenberg is a notable inventor based in Solon, Ohio, known for his contributions to the field of controlled release pharmaceutical formulations. With a total of two patents to his name, his work enhances the efficacy and reliability of drug delivery systems.

Latest Patents

One of Greenberg's key innovations is his patent for "Controlled Release Polyacrylic Acid Granules and a Process for Preparing the Same." This invention focuses on a method for efficiently forming polyacrylic acid granules that are flowable, possess an increased bulk density compared to standard polyacrylic acids, and produce minimal dust. These granules are especially valuable in the production of controlled release tablets, resulting in pharmaceuticals that boast significantly improved release properties compared to those made using traditional granulation techniques.

Another of his significant patents is for "Directly Compressed Solid Dosage Articles." This innovation involves the direct compression of solid dosage forms, like pharmaceutical tablets, from a compressible mixture consisting of an active ingredient, a slightly cross-linked rheology modifying polymer or copolymer, and various excipients. The process showcases a granulated powder derived from unsaturated (di)carboxylic acids, enhancing the formulation's effectiveness.

Career Highlights

Edward S Greenberg is associated with Noveon IP Holdings Corporation, a company that focuses on advancing innovative technologies in specialty chemicals. His role at the company underscores his commitment to improving pharmaceutical formulations and delivering cutting-edge solutions in medication delivery.

Collaborations

Throughout his career, Greenberg has collaborated with notable colleagues, including William Robert Wilber and Jian-Hwa Guo. These partnerships have fostered an environment of innovation and shared expertise, leading to significant advancements in the field of controlled release pharmaceuticals.

Conclusion

Edward S Greenberg stands out as a pivotal figure in the development of controlled release technologies. His patents and collaborations reflect a dedication to enhancing pharmaceutical efficacy through innovative granulation techniques. As the demand for advanced medication delivery systems continues to grow, Greenberg's contributions will undoubtedly play a crucial role in shaping the future of pharmaceutical science.